Joseph L. Turner

Chief Financial Officer, MYOGEN INC.

Companies

Arcutis Biotherapeutics, Inc.Board member Jan 30, 2020 to Jun 3, 2022¹
Viridian Therapeutics, Inc.\DEBoard member Feb 13, 2017 to Feb 8, 2021²
Corcept TherapeuticsBoard member Aug 5, 2010 to Jun 23, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arcutis Biotherapeutics, Inc. ARQT4,312 shares⁴$140.1K at $32.50Jun 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 1, 2022Granted 4,312 shares of Arcutis Biotherapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArcutis Biotherapeutics, Inc., Board member
2
SEC EDGARViridian Therapeutics, Inc.\DE, Board member
3
SEC EDGARCorcept Therapeutics, Board member
4
SEC EDGARArcutis Biotherapeutics, Inc. shares after the filing of Jun 1, 2022